Sector | Information Technology | Compare with Sector peers |
Industry | IT - Software | Compare with Industry peers |
Website | http://www.takesolutions.com | |
Market Cap | 306.22 Cr. | |
Enterprise Value(EV) | 336.08 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -4.39 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 31.14 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 6.75 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 3.06 | Calculated using Price: 20.70 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 14.79 Cr. | 147,934,000 Shares |
FaceValue | 1 | |
About Take Solutions Ltd. | ||
The company delivers domain-intensive services in Life Sciences and Supply Chain Management. The company offers clients a unique combination of full service Clinical, Regulatory and Safety services with unique technology expertise. The Company's services span clinical trials to regulatory submissions to post-marketing strategy with insights derived through proprietary industry network forums. |
1 Day |
|
-3.99% |
1 Week |
|
+0.63% |
1 Month |
|
-27.11% |
3 Month |
|
-11.42% |
6 Month |
|
-5.65% |
1 Year |
|
+46.91% |
2 Year |
|
-29.11% |
5 Year |
|
-84.64% |
10 Year |
|
-37.56% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 16.08 | 21.61 | 19.05 | 14.37 | 12.61 | -0.71 | -33.78 | -12.9 | -33.82 | |
Return on Capital Employed (%) | 13.91 | 18.78 | 17.74 | 14.91 | 13.21 | 1.38 | -21.31 | -5.19 | -19.83 | |
Return on Assets (%) | 8.96 | 11.69 | 11.32 | 9.96 | 8.55 | -0.46 | -21.09 | -5.44 | -6.51 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 524 | 631 | 911 | 1,328 | 1,518 | 1,575 | 1,125 | 181 | 109 | 102 | |
Non Curr. Liab. | 26 | 99 | 81 | 89 | 80 | 219 | 178 | 33 | 12 | 8 | |
Curr. Liab. | 316 | 443 | 336 | 415 | 724 | 660 | 524 | 148 | 101 | 101 | |
Minority Int. | 56 | 40 | 42 | 8 | 9 | 10 | 0 | 0 | |||
Equity & Liab. | 922 | 1,214 | 1,369 | 1,840 | 2,331 | 2,464 | 1,826 | 1,221 | 222 | 211 | |
Non Curr. Assets | 397 | 587 | 590 | 662 | 1,159 | 1,266 | 965 | 134 | 132 | 134 | |
Curr. Assets | 525 | 626 | 779 | 1,178 | 1,172 | 1,199 | 861 | 190 | 90 | 76 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 922 | 1,214 | 1,369 | 1,840 | 2,331 | 2,464 | 1,826 | 1,221 | 222 | 211 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 730 | 1,030 | 1,345 | 1,587 | 2,039 | 2,213 | 774 | 653 | 189 | 90 | |
Other Income | 8 | 21 | 13 | 6 | 11 | 26 | 12 | 17 | 8 | 0 | |
Total Income | 739 | 1,051 | 1,357 | 1,594 | 2,050 | 2,239 | 786 | 669 | 198 | 90 | |
Total Expenditure | -620 | -866 | -1,082 | -1,281 | -1,656 | -2,044 | -847 | -643 | -208 | -77 | |
PBIDT | 118 | 185 | 275 | 313 | 394 | 195 | -61 | 27 | -11 | 12 | |
Interest | -13 | -15 | -23 | -21 | -25 | -41 | -37 | -29 | -7 | -8 | |
Depreciation | -20 | -25 | -87 | -104 | -154 | -167 | -115 | -76 | -17 | -11 | |
Taxation | -5 | -20 | -19 | -28 | -37 | 2 | -14 | -5 | -2 | -1 | |
Exceptional Items | -225 | -10 | -8 | ||||||||
PAT | 80 | 125 | 146 | 160 | 178 | -11 | -452 | -83 | -47 | -15 | |
Minority Interest | -10 | -5 | -3 | 1 | -1 | -1 | -2 | 0 | 0 | ||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 70 | 120 | 143 | 160 | 177 | -12 | -452 | -782 | -100 | -65 | |
Adjusted EPS | 6 | 10 | 11 | 11 | 12 | -1 | -31 | -54 | -7 | -4 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 100 | 74 | 148 | 56 | 121 | 104 | 211 | 135 | 120 | 20 | |
Cash Fr. Inv. | -91 | -16 | -257 | -129 | -179 | -485 | -236 | -57 | -31 | -2 | |
Cash Fr. Finan. | -7 | -11 | 114 | 56 | 302 | 100 | 21 | -84 | -55 | -36 | |
Net Change | 2 | 46 | 5 | -17 | 244 | -281 | -4 | -6 | 35 | -18 | |
Cash & Cash Eqvt | 72 | 121 | 91 | 74 | 317 | 47 | 45 | 39 | 74 | 11 |
Thu, 28 Mar 2024
Closure of Trading Window Intimation of Trading Window Closure for the quarter and year ending March 31 2024 pursuant to SEBI(Prohibition of Insider Trading) Regulations 2015 |
Wed, 14 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Copy of Newspaper Publication |
Tue, 13 Feb 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday February 13 2024 We wish to inform you that the Board of Directors of the Company in its meeting held on Tuesday February 13 2024 approved the following:1. Unaudited financial results of the Company (Standalone) together with its subsidiaries (Consolidated) for the quarter and nine months ended December 31 2023 as recommended by the Audit Committee. Copy of the same in the prescribed format in terms of Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) (LODR) Regulations 2015 along with the Limited Review Report by the Statutory Auditors is enclosed herewith as Annexure-I |
Thu, 28 Mar 2024 |
High Delivery Percentage |
Higher Delivery Quantity |
Higher Delivery Quantity and Percentage |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |